SALOME Study: Heroin Addiction (5/7)

SALOME Study: Heroin Addiction (5/7) – SALOME study video part 5 talks about the NAOMI Study. The North American Opiate Medication Initiative (NAOMI) focused on people with chronic heroin addictio…

Vismodegib in basal cell carcinoma: Added benefit not proven

Filed under: drug abuse treatment outcome study

The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients with two forms of basal cell carcinoma (BCC): symptomatic metastatic BCC and locally advanced BCC inappropriate for surgery or radiotherapy. … Based on the study …
Read more on The Almagest